These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29420454)

  • 1. Systemic lupus erythematosus: disease activity may influence the release of endothelial microparticles?
    Cicarini WB; Ferreira KS; Loures CMG; Consoli RV; Neiva CLS; Pádua PM; Nunes FFC; Alves LCV; Reis EA; Toledo VPCP; Lwaleed BA; Carvalho MG
    Blood Coagul Fibrinolysis; 2018 Mar; 29(2):189-195. PubMed ID: 29420454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus.
    Parker B; Al-Husain A; Pemberton P; Yates AP; Ho P; Gorodkin R; Teh LS; Alexander MY; Bruce IN
    Ann Rheum Dis; 2014 Jun; 73(6):1144-50. PubMed ID: 23644670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus.
    Nielsen CT; Østergaard O; Johnsen C; Jacobsen S; Heegaard NH
    Arthritis Rheum; 2011 Oct; 63(10):3067-77. PubMed ID: 21702008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum DNase I activity in systemic lupus erythematosus: correlation with immunoserological markers, the disease activity and organ involvement.
    Skiljevic D; Jeremic I; Nikolic M; Andrejevic S; Sefik-Bukilica M; Stojimirovic B; Bonaci-Nikolic B
    Clin Chem Lab Med; 2013 May; 51(5):1083-91. PubMed ID: 23183758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis.
    Michalska-Jakubus M; Kowal-Bielecka O; Smith V; Cutolo M; Krasowska D
    Microvasc Res; 2017 Mar; 110():24-31. PubMed ID: 27889559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life.
    Lai NS; Lu MC; Chang HH; Lo HC; Hsu CW; Huang KY; Tung CH; Hsu BB; Wu CH; Koo M
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34063379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum leucine-rich α2-glycoprotein is elevated in patients with systemic lupus erythematosus and correlates with disease activity.
    Ahn SS; Park Y; Jung SM; Song JJ; Park YB; Lee SW
    Clin Chim Acta; 2018 Nov; 486():253-258. PubMed ID: 30118672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of sex on the number of circulating endothelial microparticles and microRNA expression in middle-aged adults.
    Bammert TD; Hijmans JG; Kavlich PJ; Lincenberg GM; Reiakvam WR; Fay RT; Greiner JJ; Stauffer BL; DeSouza CA
    Exp Physiol; 2017 Aug; 102(8):894-900. PubMed ID: 28568648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of disease activity with depression and anxiety in systemic lupus erythematosus: A comparison of SLEDAI-2K and SLE-DAS.
    Yang L; Gu B; Wang X; Ren Q; Shen M; Su D
    Rheumatology (Oxford); 2024 Feb; ():. PubMed ID: 38305645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Subtypes of Microparticle-containing Immune Complexes Are Associated with Disease Activity, Damage, and Carotid Intima-media Thickness in Systemic Lupus Erythematosus.
    Fortin PR; Cloutier N; Bissonnette V; Aghdassi E; Eder L; Simonyan D; Laflamme N; Boilard E
    J Rheumatol; 2016 Nov; 43(11):2019-2025. PubMed ID: 27585687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies.
    Bentow C; Lakos G; Martis P; Wahl E; Garcia M; Viñas O; Espinosa G; Cervera R; Sjöwall C; Carmona-Fernandes D; Santos MJ; Hanly JG; Mahler M
    Lupus; 2016 Jul; 25(8):864-72. PubMed ID: 27252263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.
    Touma Z; Gladman DD; Ibañez D; Taghavi-Zadeh S; Urowitz MB
    J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QRISK3-based analysis of cardiovascular risk factors in patients with long-term but well-controlled systemic lupus erythematosus.
    Wang SL; Li W; Li TF; Liang X; Yan YL; Liu SY
    Am J Transl Res; 2022; 14(5):3247-3260. PubMed ID: 35702101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
    Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microparticles in neuropsychiatric systemic lupus erythematosus.
    Crookston KP; Sibbitt WL; Chandler WL; Qualls CR; Roldan CA
    Int J Rheum Dis; 2013 Feb; 16(1):72-80. PubMed ID: 23441775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus.
    Choe JY; Park SH; Kim SK
    Lupus; 2014 Dec; 23(14):1486-93. PubMed ID: 25124677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction in systemic lupus patients with low disease activity: evaluation by quantification and characterization of circulating endothelial microparticles, role of anti-endothelial cell antibodies.
    Duval A; Helley D; Capron L; Youinou P; Renaudineau Y; Dubucquoi S; Fischer AM; Hachulla E
    Rheumatology (Oxford); 2010 Jun; 49(6):1049-55. PubMed ID: 20211868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.